Skip to main content
. Author manuscript; available in PMC: 2013 Dec 26.
Published in final edited form as: JAMA. 2013 Jun 26;309(24):10.1001/jama.2013.6882. doi: 10.1001/jama.2013.6882

Figure 2.

Figure 2

Use of Advanced Treatment Technologies Among Prostate Cancer Patients Who Are the Least Likely to Benefit

The percentage of treatment was adjusted for age, race, socioeconomic class, comorbidity, tumor grade, year of diagnosis, and Surveillance, Epidemiology, and End Results region. Use of intensity-modulated radiotherapy (IMRT) and robotic prostatectomy both increased among men who stand the least to gain in terms of survival (both P<.001 for trend). The majority of these patients were treated with IMRT. Error bars indicate 95% CI.